QIAGEN Ltd.
Industry / private company
Location:
Manchester,
United Kingdom (GB)
ISNI: 0000000404513823
ROR: https://ror.org/04hyg4h58
Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment (2020)
Wang S, Burgess M, Major C, English A, Sweeney M, Hartmann A
Journal article
Clinical Performance of QIAGEN Fibroblast Growth Factor Receptor (FGFR) Assay for the Detection of FGFR Alterations in Erdafitinib-Treated Patients with Metastatic or Locally Advanced, Surgically Unresectable, Urothelial Cancer (2019)
Major C, Wang S, Burgess M, English A, Sweeney M, Hartmann A
Conference contribution